Results 81 to 90 of about 20,680 (257)
, 2009 This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of seborrheic ...
Kompella, Anu
core +1 more source
Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection
Journal of the European Academy of Dermatology and Venereology, 2020 Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. The most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute ...
A. Ehsani, M. Nasimi, Zeinab Bigdelo
semanticscholar +1 more source
A case of Blaschkoid pityriasis rosea following COVID-19 vaccination: A rare exceptional occurrence
Nasza Dermatologia Online, 2022 The launch of COVID-19 vaccines in India has raised the expectations of the dreadful COVID-19 pandemic ending in the future. Various mild and benign cutaneous manifestations of the different forms of the COVID-19 vaccine have been documented.
A. Arora, A. Mohta, P. Soni
semanticscholar +1 more source
A Review of Hand Eczema Subtypes: Clinical Features, Biomarkers and Treatment Strategies
Contact Dermatitis, Volume 92, Issue 6, Page 421-435, June 2025.ABSTRACT Hand eczema is a common dermatological condition that significantly impairs quality of life. The classification of hand eczema has been considered an essential step for its management. The diagnosis of hand eczema relies on the aetiological and clinical features of hand lesions, a process complicated by the heterogeneous presentations and the ...
David Pesqué +5 more
wiley +1 more source
Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey [PDF]
, 2023 Purpose: After the emergence of the pandemic caused by the COVID-19 virus, vaccination with various vaccines has started to be implemented across the world.
Demirseren, Düriye Deniz +15 more
core +1 more source
Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea
Journal of Korean medical science, 2022 Background Pityriasis rosea (PR) is a papulosquamous eruption with generally unknown origin but suspected to be related to viral etiologies. The clinicopathological spectrum of several disorders with viral etiologies has been altered after the ...
D. H. Kim +4 more
semanticscholar +1 more source
Indian Journal of Dermatology, Venereology and Leprology, 2005 Recent controversies on the etiology, diagnosis and treatment have led to increased interest in pityriasis rosea (PR). We review these aspects of the disease. PR is universal. The incidence is around 0.68 per 100 dermatological patients, or 172.2 per 100,000 person-years. The prevalence in people aged between 10 and 29 years is 0.6%. The male to female
Antonio Chuh +4 more
openaire +3 more sources
The Erythemato-Squamous Dermatology Diseases Severity Determination using Self-Organizing Map [PDF]
, 2015 A new approach based on the implementation of Self Organizing Map is presented for automated detection of erythemato-squamous diseases. The purpose of clustering techniques is in order to determinate the severity of erythemato-squamous dermatology ...
Alfita, Riza +7 more
core +2 more sources
Pityriasis rosea revealing a viral Hepatitis B
Revue Malienne d’Infectiologie et de Microbiologie, 2017 Pityriasis rosea, described by Gibert in 1860, is a frequent, benign, transient dermatosis, with unknown etiology that affects especially young adults. It is believed to be a consequence of a viral infection, but this argument is not convincing.
Y Karabinta +10 more
doaj +1 more source
Clinicopathological Study of Non-Infectious Erythaematous Papulosquamous Skin Diseases [PDF]
Journal of Clinical and Diagnostic Research, 2016 Introduction: Papulosquamous diseases are characterized by scaly papules and plaques with similar clinical picture which amounts to confusion and hence, a definitive histopathological diagnosis goes a long way in treatment of such diseases.
Sushma Hosamane +3 more
doaj +1 more source